Insider Transactions in Q1 2023 at Icu Medical Inc (ICUI)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 08
2023
|
Virginia Ruth Sanzone VP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
1,196
-18.17%
|
$186,576
$156.17 P/Share
|
|
Mar 08
2023
|
Virginia Ruth Sanzone VP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
2,272
+25.66%
|
-
|
|
Mar 08
2023
|
Daniel Woolson VP, GM-Infusion Capital |
SELL
Payment of exercise price or tax liability
|
Direct |
894
-7.15%
|
$139,464
$156.17 P/Share
|
|
Mar 08
2023
|
Daniel Woolson VP, GM-Infusion Capital |
BUY
Exercise of conversion of derivative security
|
Direct |
2,020
+13.91%
|
-
|
|
Mar 08
2023
|
Christian B. Voigtlander Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,163
-5.38%
|
$181,428
$156.17 P/Share
|
|
Mar 08
2023
|
Christian B. Voigtlander Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,209
+9.27%
|
-
|
|
Mar 08
2023
|
Vivek Jain Chairman and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,329
-5.3%
|
$207,324
$156.17 P/Share
|
|
Mar 08
2023
|
Vivek Jain Chairman and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,525
+9.14%
|
-
|
|
Mar 08
2023
|
Brian Michael Bonnell Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,163
-8.57%
|
$181,428
$156.17 P/Share
|
|
Mar 08
2023
|
Brian Michael Bonnell Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,209
+13.99%
|
-
|
|
Mar 07
2023
|
Virginia Ruth Sanzone VP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
564
-11.57%
|
$88,548
$157.47 P/Share
|
|
Mar 07
2023
|
Virginia Ruth Sanzone VP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
1,072
+18.03%
|
-
|
|
Mar 07
2023
|
Daniel Woolson VP, GM-Infusion Capital |
SELL
Payment of exercise price or tax liability
|
Direct |
428
-3.92%
|
$67,196
$157.47 P/Share
|
|
Mar 07
2023
|
Daniel Woolson VP, GM-Infusion Capital |
BUY
Exercise of conversion of derivative security
|
Direct |
965
+8.13%
|
-
|
|
Mar 07
2023
|
Christian B. Voigtlander Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,129
-5.5%
|
$177,253
$157.47 P/Share
|
|
Mar 07
2023
|
Christian B. Voigtlander Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,145
+9.46%
|
-
|
|
Mar 07
2023
|
Vivek Jain Chairman and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,694
-6.98%
|
$265,958
$157.47 P/Share
|
|
Mar 07
2023
|
Vivek Jain Chairman and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,218
+11.71%
|
-
|
|
Mar 07
2023
|
Brian Michael Bonnell Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,129
-9.03%
|
$177,253
$157.47 P/Share
|
|
Mar 07
2023
|
Brian Michael Bonnell Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,145
+14.65%
|
-
|
|
Mar 06
2023
|
Virginia Ruth Sanzone VP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
839
-18.08%
|
$135,079
$161.25 P/Share
|
|
Mar 06
2023
|
Virginia Ruth Sanzone VP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
1,595
+25.58%
|
-
|
|
Mar 06
2023
|
Daniel Woolson VP, GM-Infusion Capital |
SELL
Payment of exercise price or tax liability
|
Direct |
626
-5.92%
|
$100,786
$161.25 P/Share
|
|
Mar 06
2023
|
Daniel Woolson VP, GM-Infusion Capital |
BUY
Exercise of conversion of derivative security
|
Direct |
1,417
+11.82%
|
-
|
|
Mar 06
2023
|
Christian B. Voigtlander Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,420
-12.47%
|
$872,620
$161.25 P/Share
|
|
Mar 06
2023
|
Christian B. Voigtlander Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,296
+17.84%
|
-
|
|
Mar 06
2023
|
Vivek Jain Chairman and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,194
-12.71%
|
$997,234
$161.25 P/Share
|
|
Mar 06
2023
|
Vivek Jain Chairman and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
11,767
+18.43%
|
-
|
|
Mar 06
2023
|
Brian Michael Bonnell Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,420
-21.2%
|
$872,620
$161.25 P/Share
|
|
Mar 06
2023
|
Brian Michael Bonnell Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,296
+27.49%
|
-
|
|
Feb 02
2023
|
Daniel Woolson VP, GM-Infusion Capital |
SELL
Open market or private sale
|
Direct |
1,731
-15.91%
|
$346,200
$200.0 P/Share
|